This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Young, C. W. Articles by Dowling, M. D. Search for Related Content PubMed PubMed Citation Articles by Young, C. W. Articles by Dowling, M. D., Jr.

Antipyretic Effect of Cycloheximide, an Inhibitor of Protein Synthesis, in Patients with Hodgkin's Disease or Other Malignant Neoplasms¹

Memorial Sloan-Kettering Cancer Center, New York, New York 10021

Infusion of cycloheximide i.v., an antibiotic known to inhibit synthesis of protein, at a rate of 0.2 mg/kg/hr, reliably caused lysis of fever in 15. chronically febrile patients with Hodgkin's disease who did not have detectable bacterial, fungal, or viral infection. Antipyretic effects were also seen in some patients with reticulum cell sarcoma, lymphosarcoma, acute leukemia, histocytic medullary reticulosis, plasma cell myeloma, carcinoma of the lung, and carcinoma of the cervix. The drug failed to produce defervescence in four patients with normal granulocyte reserves, who were febrile due to bacterial infection. When infused at a rate of 0.2 mg/kg/hr, the drug apparently caused an acute alteration of protein metabolism in man in that plasma amino acid nitrogen rose acutely while plasma levels of muramidase and ribonuclease fell during the period of the infusion. The data suggest that continuing synthesis of protein may be involved in nonbacterial fever of neoplastic disease. Mammalian granulocytes and monocytes are known to elaborate a pyrogenic protein following appropriate stimulation; it is suggested that in some types of neoplastic disease, particularly Hodgkin's disease, tumor cells may produce and release a pyrogenic protein and that drug-induced inhibition of its synthesis is responsible for the observed lysis of fever.

¹ The work was supported in part by Grants CA 08748 and CA 05826 from the National Cancer Institute and by a grant from the Bodman Foundation.

Received 2/21/74. Accepted 2/ 4/75.

This article has been cited by other articles:

				G. Gausdal, B. T. Gjertsen, E. McCormack, P. Van Damme, R. Hovland, C. Krakstad, O. Bruserud, K. Gevaert, J. Vandekerckhove, and S. O. Doskeland Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death Blood, March 1, 2008; 111(5): 2866 - 2877. [Abstract] [Full Text] [PDF]

				A Lucic, V Bradamante, M Peraica, B Radic, A-M Domijan, and R Fuchs Changes in plasma lipids after a non-lethal dose of cycloheximide in rats Human and Experimental Toxicology, May 1, 2003; 22(5): 245 - 248. [Abstract] [PDF]